The company plans to use the funds for strategic investments including research laboratory development, microorganism multiplication capacity expansion, irrigation system upgrades at its Zimnicea farm, and international market expansion.

The capital increase comes as Norofert implements its medium and long-term development strategy, with particular focus on strengthening operations in the United States and Brazil. 

"The capital market plays an essential role in supporting Norofert's strategy," said Vlad Popescu, President of the Board. "We have made investments of approximately RON 30 million (around €6 million) in development, research, and innovation in almost six years since listing. This operation provides the resources needed to accelerate investments and to strengthen operations in the United States and Brazil, markets with a strategic role in our growth plans."

Existing shareholders will have preemptive rights to subscribe for new shares during a 10-day period from February 10-23, 2026. Five preemptive rights are required to subscribe for one new share at RON 2.7 per share. Any unsubscribed shares will be offered through a private placement within 10 business days of the first stage closing.

Founded in 2000 by the Popescu family, Norofert operates 85 products in its portfolio serving both conventional and organic farmers. The company has raised RON 14 million (€2.75 million) through capital increases and RON 18.5 million (€3.64 million) through corporate bond placements since its 2020 listing.